# A Pivotal Trial to Establish the Efficacy and Long-term Safety of the Parachute Implant System

> **NCT01614652** · PHASE3 · TERMINATED · sponsor: **CardioKinetix, Inc** · enrollment: 331 (actual)

## Conditions studied

- Congestive Heart Failure
- Left Ventricular (LV) Systolic Dysfunction

## Interventions

- **DEVICE:** CardioKinetix Parachute Implant and All Appropriate Medical Therapy (AAMT)

## Key facts

- **NCT ID:** NCT01614652
- **Lead sponsor:** CardioKinetix, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-12
- **Primary completion:** 2017-06
- **Final completion:** 2017-06
- **Target enrollment:** 331 (ACTUAL)
- **Why stopped:** Company is closed
- **Last updated:** 2017-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01614652

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01614652, "A Pivotal Trial to Establish the Efficacy and Long-term Safety of the Parachute Implant System". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01614652. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*